Cargando…
Increased expression of Mer tyrosine kinase in circulating dendritic cells and monocytes of lupus patients: correlations with plasma interferon activity and steroid therapy
INTRODUCTION: The requirement for the immunoregulatory Mer tyrosine kinase (Mer) for optimal removal of apoptotic cells prompted us to look at its expression in systemic lupus erythematosus (SLE), in which apoptotic cell clearance is abnormal. We compared the levels of expression of Mer in normal hu...
Autores principales: | Hilliard, Brendan A, Zizzo, Gaetano, Ulas, Mehriban, Linan, Margaret K, Schreiter, Jessica, Cohen, Philip L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4060208/ https://www.ncbi.nlm.nih.gov/pubmed/24650765 http://dx.doi.org/10.1186/ar4517 |
Ejemplares similares
-
Circulating levels of soluble MER in lupus reflect M2c activation of monocytes/macrophages, autoantibody specificities and disease activity
por: Zizzo, Gaetano, et al.
Publicado: (2013) -
Editorial: The key role of Mer receptor tyrosine kinase: where inflammation ends and fibrosis begins
por: Zizzo, Gaetano, et al.
Publicado: (2023) -
Delayed Apoptotic Cell Clearance and Lupus-like Autoimmunity in Mice Lacking the c-mer Membrane Tyrosine Kinase
por: Cohen, Philip L., et al.
Publicado: (2002) -
The PPAR-γ antagonist GW9662 elicits differentiation of M2c-like cells and upregulation of the MerTK/Gas6 axis: a key role for PPAR-γ in human macrophage polarization
por: Zizzo, Gaetano, et al.
Publicado: (2015) -
The Expression and Clinical Significance of Different Forms of Mer Receptor Tyrosine Kinase in Systemic Lupus Erythematosus
por: Zhu, Huaqun, et al.
Publicado: (2014)